Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D002746:Chlorpromazine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004952:Esters; D005260:Female; D005476:Fluphenazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced*; D009966:Orphenadrine / Q000627:therapeutic use; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000209:etiology; D013997:Time Factors
D004952:Esters; D010919:Placebos; D009966:Orphenadrine; D005476:Fluphenazine; D002746:Chlorpromazine